Lung cancer is a leading cause of cancer death for both men and women. Lung Cancer is an epithelial cancer, that arises from the epithelial cells of the lung of the central bronchi to terminal alveoli. It represents ~85% of all lung cancer diagnoses. Significant efforts have been made over the years and are still ongoing to discover new drugs to treat advanced and metastatic disease. There remains significant unmet need, in particular, at both ends of the disease spectrum for patients with early stage medically inoperable peripheral lung tumors and for patients with metastatic disease.

Peripheral tumors

There are currently limited options for the treatment of solitary peripheral tumors, which are treated either with percutaneous surgery or ablation technologies, which are associated with significant morbidities. The advent of robotic bronchoscopy is opening new opportunities to diagnose these tumors earlier and treat them in a non-invasive manner. Padeliporfin VTP therapy is currently being developed for patients with peripheral lung tumors using a robotic assisted approach.